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Abstract
Aims/hypothesis We assessed the heterogeneity of insulin
secretion from human isolated beta cells and its regulation
by cell-to-cell contacts.
Methods Insulin secretion from single and paired cells was
assessed by a reverse haemolytic plaque assay. The
percentage of plaque-forming cells, the mean plaque area
and the total plaque development were evaluated after 1 h
of stimulation with different secretagogues.
Results Not all beta cells were surrounded by a haemolytic
plaque under all conditions tested. A small fraction of the
beta cell population (20%) secreted more than 90% and 70%
of total insulin at 2.2 and 22.2 mmol/l glucose, respectively.
Plaque-forming cells, mean plaque area and total plaque
development were increased at 12.2 and 22.2 compared
with 2.2 mmol/l glucose. Insulin secretion of single beta
cells was similar at 12.2 and 22.2 mmol/l glucose. Insulin
secretion of beta cell pairs was increased compared with
that of single beta cells and was higher at 22.2 than at
12.2 mmol/l glucose. Insulin secretion of beta cells in
contact with alpha cells was also increased compared with
single beta cells, but was similar at 22.2 compared with
12.2 mmol/l glucose. Delta and other non-beta cells did not
increase insulin secretion of contacting beta cells compared
with that of single beta cells. Differences in insulin secretion
between 22.2 and 12.2 mmol/l glucose were observed in
murine but not in human islets.
Conclusions/interpretation Human beta cells are highly
heterogeneous in terms of insulin secretion so that a small
fraction of beta cells contributes to the majority of insulin
secreted. Homologous and heterologous intercellular con-
tacts have a significant impact on insulin secretion and this
could be related to the particular architecture of human islets.
Keywords Beta cells . Heterogeneity . Human islets .
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Abbreviations
CMRL Connaught Medical Research Laboratory
IBMX 3-isobutyl-1-methylxanthine
IEQ islet equivalent
KRB 2.2 KRB Hepes buffer supplemented with 0.1%
BSA and 2.2 mmol/l glucose
MPA mean plaque area
PFC plaque-forming cells or cell pairs
PMA phorbol-12-myristate-13-acetate
RHPA reverse haemolytic plaque assay
TPD total plaque development
Introduction
Endocrine cells are not randomly distributed within
pancreatic islets. In most laboratory animals, islets consist
of a core of insulin-secreting beta cells surrounded by
alpha, delta and pancreatic polypeptide cells, which secrete
glucagon, somatostatin and pancreatic polypeptide respec-
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tively [1]. This complex architecture, which favours
homologous cell-to-cell contacts, has been shown to be
crucial for the normal function of the islet [2–5]. In animal
models of diabetes, the well-defined islet architecture is
disturbed [6, 7] so that glucagon- and somatostatin-
containing cells are intermingled with beta cells. The same
altered cellular organisation was reproduced in vitro by
exposing islet cells to cytokines known to be secreted by
leucocytes that infiltrate islets during diabetes onset [8].
The importance of homologous contacts between beta cells
is further supported by the observation in rodents that the
functioning of isolated beta cells is heterogeneous [9–13]. For
instance, beta cells respond unequally to glucose stimulation
in terms of insulin secretion and biosynthetic activity [12, 14,
15]. It has been suggested that intercellular contacts
coordinate the functioning of beta cells by homogenising
and synchronising their activities. This coordination is
mediated at least in part by junctional structures and cell
adhesion molecules. Specifically, beta cells are inter-
connected by gap junctions, which form channels across
the extracellular space and allow direct exchanges of small
cytoplasmic molecules, ensuring electrical coupling and
promoting insulin secretion [16]. Adhesion molecules such
as integrins, cadherins and neural cell adhesion molecule
have been described in islets and they somehow influence
insulin secretion and are also involved in maintaining correct
islet architecture [17–19].
The cytoarchitecture of human islets has been examined in
detail only recently [5, 20]. Compared with animal models,
the pattern of distribution of islet cells is unique in that the
different endocrine cell types are distributed throughout the
islet and not sorted into central and peripheral compart-
ments. In addition, this structural dissimilitude has been
associated with functional differences. Indeed, in contrast to
mouse or rat islets, human islets displayed oscillations in
intracellular calcium concentration that were not synchron-
ised between beta cells. It has been suggested that this
discontinuous activity of beta cells originates from the
particular layout of beta cells in human islets [5].
Considering these above observations, we analysed
whether heterogeneity in terms of insulin secretion also
exists between human beta cells and how insulin secretion
is affected by intercellular contacts. To this end, human
islets isolated from different pancreases were dissociated
and insulin secretion from single beta cells and aggregated
cell pairs comprising beta and non-beta cells were studied
by a reverse haemolytic plaque assay (RHPA) [21].
Methods
Islet isolation Human islets were isolated from human
pancreases removed from brain-dead heart-beating donors.
The use of human tissue for research was approved by our
local institutional ethical committee, and our centre is a
member of the European Consortium for Islet Transplanta-
tion for the islet research distribution programme, under the
supervision of the Juvenile Diabetes Research Foundation.
Islets were isolated and purified using Ricordi’s automated
method [22] with local modifications [23]. After isolation,
islets were suspended in Connaught Medical Research
Laboratory (CMRL) medium containing 5.6 mmol/l glucose
and 10% FCS, and incubated for 24 h at 37°C and at 24°C
thereafter.
Adult male DBA/1 mice were purchased from Janvier
laboratories (Le Genest-Saint-Isle, France). All experimen-
tal protocols were reviewed and approved by the Institu-
tional Animal Care and Use Committee, Department of
Territory, State of Geneva. Mouse islets were isolated and
purified using techniques previously described [17, 24].
Viability, as assessed by propidium iodide/fluorescein
diacetate staining, was always higher than 80%. Isolated
islets were then kept for 24 h and at 37°C in RPMI medium
containing 10% FCS before static incubation tests were
done.
Islet dissociation Aliquots of 1,000 islet equivalents (IEQ;
average islet diameter 150 μm) were rinsed twice with
10 ml PBS, resuspended in 1 ml Accutase (Innovative Cell
Technologies, San Diego, CA, USA) and incubated at 37°C
with gentle pipetting every 30 s. From 5 min onwards,
complete cell dissociation was checked by microscopic
observation of 10 μl aliquots sampled every min. When
dissociation was considered to be complete (usually
between 7 and 10 min), cells were diluted with 10 ml cold
CMRL containing 10% FCS (vol./vol.). Before analysis by
RHPA, cells were rinsed and incubated in this medium for
either 1 to 2 h (in a first set of experiments) or for 24 h (in a
second set of experiments) in order to increase cell-to-cell
aggregation.
Insulin secretion by RHPA Cunningham glass chambers
(60 μl) were coated with 0.1 mg/ml poly-L-lysine (molecular
mass 150,000–300,000; Sigma-Aldrich, Buchs, Switzerland).
Islet cells were then rinsed with KRB Hepes buffer
(125 mmol/l NaCl, 4.74 mmol/l KCl, 1 mmol/l CaCl2,
1.2 mmol/l KH2PO4, 1.2 mmol/l MgSO4, 5 mmol/l NaHCO3,
25 mmol/l HEPES, pH 7.4) supplemented with 0.1% BSA
(wt/vol.) and 2.2 mmol/l glucose (KRB 2.2). Then, islets
cells were diluted in KRB 2.2 to a density of 25×105 per ml
and erythrocytes (sheep blood; Dade Behring, Servion,
Switzerland) previously coated with Protein A (Amersham
Bioscience, Dübendorf, Switzerland) were added to the cell
suspension at a concentration of 5% (vol./vol.). This final
preparation (60 μl) was introduced into a Cunningham
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chamber and placed in a damp box at 37°C. After 1 h,
chambers were rinsed three times with 200 μl KRB 2.2,
once with 200 μl testing buffer and once again with 100 μl
testing buffer supplemented with a guinea pig polyclonal
anti-insulin antibody prepared as described by Wright
et al. [25] (dilution 1:300). Testing buffers were KRB 2.2
and KRB supplemented (1) with 12.2 mmol/l glucose,
(2) with 22.2 mmol/l glucose, (3) with 2.2 mmol/l
glucose + 25 mmol/l KCl, (4) with 22.2 mmol/l glucose +
25 mmol/l KCl and (5) with 22.2 mmol/l glucose +
25 mmol/l KCl + 0.5 mmol/l 3-isobutyl-1-methylxanthine
(IBMX) + 100 nmol/l phorbol-12-myristate-13-acetate
(PMA) + 10 µmol/l forskolin. After 1 h at 37°C, chambers
were rinsed with KRB 2.2, then with this same buffer
supplemented with guinea pig complement (dilution 1:40;
Dade Behring). After 1 h at 37°C, chambers were rinsed
with 0.04% Trypan Blue solution and incubated 5 min at
room temperature, rinsed once with KRB 2.2 and finally
filled with Bouin’s fixation solution.
Immunocytochemistry To identify endocrine islet cells in
RHPA, the Cunningham chambers were un-mounted and
slides with fixed cells were rinsed in PBS, passed through a
series of graded ethanols (30, 50, 70 and 90% [vol./vol.]),
incubated for 15 min in PBS supplemented with 0.1% BSA
and exposed for 1 h at room temperature to primary antibodies,
diluted in PBS containing 0.1% BSA (wt/vol.). For simple
staining, we used a guinea pig anti-insulin antibody (1:500
prepared as described by Wright et al. [25]); for double
staining, we used this same antibody in combination with a
mouse anti glucagon (1:400; Sigma) or a rabbit anti
somatostatin antibody (1:3,000; Dako, Glostrup, Denmark).
After rinsing with PBS, slides were incubated for 1 h at room
temperature with secondary antibodies, diluted in PBS. For
simple staining we used an FITC-conjugated goat anti-guinea
pig antibody (1:400; Jackson ImmunoResearch Laboratories,
West Grove, PA, USA); for double staining we used this
same antibody in combination with a tetramethylrhodamine-
conjugated donkey anti-mouse or a tetramethylrhodamine-
conjugated donkey anti-rabbit antibody (1:200 and 1:900
respectively; Jackson ImmunoResearch Laboratories). After a
last rinsing with PBS, slides were coverslipped with a
solution of 0.02% of paraphenylenediamine in PBS–glycerol
(1:2, vol./vol.) and sealed.
RHPA analysis Slides were examined under a microscope
(Zeiss Axiophot, Göttingen, Germany) with both phase-
contrast and fluorescence illumination. Analysis was
restricted to Trypan Blue-negative cells. Beta cells were
identified by their fluorescent labelling. When simple
staining was performed, single beta cells, beta cell pairs
and pairs comprising one beta and one non-beta cell were
analysed. Altogether, these cells represented 81±13%
(mean±SD, n=14) of the total beta cell population. Single
beta cells represented 50±13% (mean±SD, n=14) of the
total beta cell population. When double staining was
performed, single beta cells in direct contact with alpha
and delta cells were analysed additionally. With phase-
contrast illumination and using a calibrated grid eyepiece,
diameters of haemolytic plaques formed around secreting
single beta cells and cell pairs were measured. The
percentage of plaque-forming cells or cell pairs (PFC) and
the corresponding mean plaque area (MPA) were calculat-
ed. The total plaque development (TPD) reflecting the total
amount of insulin secreted by 100 cells or cell pairs was
calculated by multiplying the PFC by the MPA.
Immunohistology Mouse pancreases and human pancreas
samples were fixed in 4% paraformaldehyde, then embed-
ded in paraffin and sectioned. Sections were incubated for
15 min in PBS supplemented with 0.1% BSA and exposed
for 2 h to an anti-glucagon antibody (1:100; Dako) and
subsequently for 1 h to FITC-conjugated goat anti-rabbit
antibody (1:500; Jackson ImmunoResearch).
Static incubation assay to assess insulin secretion from
intact islets Islets cultured for 24 h were rinsed three times
with KRB 2.2 and aliquots of 50 IEQ were pre-incubated for
1 h in the same buffer at 37°C. Islets were then successively
incubated for 1 h in KRB 2.2 (basal condition), then in KRB
12.2 or 22.2 mmol/l glucose (stimulated conditions) and once
again in KRB 2.2 (re-basal condition). Incubation buffers
were collected and frozen for further insulin measurements.
After the last incubation, insulin was extracted from islets with
acid-ethanol. Insulin was measured by ELISA using an ultra-
sensitive human or mouse insulin detection kit (Mercodia,
Uppsala, Sweden).
Statistical analysis Data are expressed as means±SEM.
Statistica, version 6.0 software (Statsoft, Tulsa, OK, USA)
was used for statistical analysis. Student’s t test and one-
way ANOVA followed by least significant difference or
Tukey’s post hoc tests were used for comparison of data.
Values of p<0.05 were considered as significant.
Results
Insulin secretion of single human beta cell is heterogeneous In
RHPA, the reaction between insulin, anti-insulin antibodies
and complement induces the lysis of protein A-bearing
erythrocytes localised around secreting beta cells; beta cells
are identified by immunofluorescence (Fig. 1). Under basal
and stimulated conditions, we identified subpopulations of
beta cells surrounded or not by a haemolytic plaque
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(Fig. 1). Beta cells not surrounded by a haemolytic plaque
were observed with all secretagogues used (see below). In
addition, as illustrated in Fig. 1b–d, dimensions of
haemolytic plaques formed around beta cells were very
variable. The diameters of haemolytic plaques formed
around single beta cells in the same preparation frequently
ranged from 25 to 300 μm. As plaque area is proportional
to insulin secreted, this means that the ratio of insulin
secreted by cells with the greatest secretion to insulin
secreted by cells with the lowest secretion was ∼140.
Insulin secretion from single human beta cells in response
to glucose and other secretagogues After 1 h at 2.2
mmol/l glucose, we found few cells surrounded by a
haemolytic plaque (Fig. 1e). After 1 h at 22.2 mmol/l glucose
the number of PFC increased, although some beta cells not
surrounded by haemolytic plaque were still observed (Fig. 1f).
PFC, MPA and TPD were evaluated for single beta cells after
1 h of incubation at 2.2, 12.2 and 22.2 mmol/l glucose
(Fig. 2). At 2.2 mmol/l glucose, about 30% of beta cells were
surrounded by a haemolytic plaque. This value significantly
increased to about 70% for beta cells incubated at 12.2
mmol/l glucose (Fig. 2a). At 2.2 mmol/l glucose, the MPA
was around 2500 μm2 and increased to around 4000 µm2 for
cells incubated at 12.2 mmol/l glucose (Fig. 2b). Consequently,
TPD was three- to fourfold higher at 12.2 than at 2.2 mmol/l
glucose. No difference in PFC, MPA and TPD was observed
in cells stimulated with 12.2 or 22.2 mmol/l glucose. Values
were similar in cells isolated from islets cultured for 1 or
5 days (Fig. 2).
In addition to glucose, other secretagogues were tested on
haemolytic plaque formation from isolated human beta cells
(Fig. 3). High concentration of KCl (25 mmol/l), which
triggers membrane depolarisation, increased the number of
PFC as well as the size of haemolytic plaques at 2.2 and
22.2 mmol/l glucose (Fig. 3c,d). To maximally stimulate
insulin secretion, KRB containing 22.2 mmol/l glucose was
supplemented with 25 mmol/l KCl, 0.5 mmol/l IBMX,
100 nmol/l PMA and 10 µmol/l forskolin. Under these
Fig. 1 Heterogeneous formation of haemolytic plaques around single
beta cells. Cells were photomicrographed at the end of the RHPA after
being stained by immunofluorescence for insulin. a–d Phase–contrast
views showing single cells surrounded (b–d) or not (a) by a haemolytic
plaque. The corresponding immunofluorescence views indicate that
cells produced insulin. After 1 h stimulation with 22.2 mmol/l glucose,
beta cells surrounded by intact refringent erythrocytes (a) coexisted in
the same preparation with cells surrounded by small (b), intermediate
(c) or large (d) haemolytic plaques, which consisted of complement-
lysed erythrocytes. When photomicrographed at a lower magnification
using dark-field illumination (e, f), the plaques appear as round dark
areas centred around beta cells. At 2.2 mmol/l glucose (e), few beta cells
were surrounded by small haemolytic plaques, whereas at 22.2 mmol/l
glucose (f) the number of plaques and their size were higher. Beta cells
not surrounded by haemolytic plaque were identified by immunofluo-
rescence for insulin (arrows). Scale bar (a–d) 50 μm, (e, f) 200 μm
Fig. 2 Effect of glucose on haemolytic plaque formation around
single beta cells. One (D1) and five (D5) days after islet isolation,
single beta cells were analysed by RHPA. The percentage of PFC (a),
the MPA (b) and the TPD (c) were evaluated after 1 h stimulation with
2.2 (black bars), 12.2 (hatched bars) and 22.2 mmol/l glucose (white
bars). At D1 and D5, and for all variables analysed, values at
12.2 mmol/l glucose were higher than at 2.2 mmol/l glucose (not
significant for plaque area [b]) and did not increase any more at
22.2 mmol/l glucose. Results are means±SEM of 16 independent
experiments for 2.2 and 22.2 mmol/l glucose, and of 11 independent
experiments for 12.2 mmol/l glucose. **p<0.01 compared with
2.2 mmol/l glucose
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conditions most beta cells were surrounded by a haemolytic
plaque and plaques were larger than those formed under
any other conditions (Fig. 3e). However, even under these
conditions beta cells not surrounded by a haemolytic plaque
were still observed.
Heterogeneity of insulin secretion between donors does not
correlate with donor, pancreas and islet cell character-
istics In addition to the heterogeneous insulin secretion
observed between beta cells isolated from a same pancreas,
there is also a great variability of insulin secretion between
different pancreases (Table 1). In 15 islet cell preparations
from different donors that were stimulated with 22.2 mmol/
l glucose, PFC values ranged from 40 to 88%, MPA values
from 2,000 to 5,500 μm2 and TPD values from 90,000 to
400,000 μm2. These values did not correlate with donor
characteristics, such as age, BMI and glycaemia, ischaemia
time of pancreas, viability and percentage of beta cells
(Table 1).
The greatest proportion of insulin is secreted by a minority
of beta cells To further characterise heterogeneity of insulin
secretion, we analysed distribution of beta cells (Fig. 4a)
and corresponding TPD (Fig. 4b) according to plaque
diameters. At low glucose concentration (2.2 mmol/l), beta
cells surrounded by a small-diameter haemolytic plaque
(25–37 μm) were most frequent (7–10% of total beta cell
population). Then, percentages gradually diminished with
increasing plaque diameters. Thus, at low glucose concen-
Fig. 3 Effect of different secretagogues on haemolytic plaque
formation around beta cells. Cells were photomicrographed at low
magnification using dark-field illumination at the end of the RHPA.
Haemolytic plaques appear as round dark areas. At 2.2 mmol/l glucose
(a), the plaques were rare and small. The number and the size of the
plaques gradually increased after stimulation with 22.2 mmol/l glucose
(b), 25 mmol/l KCl (c), 22.2 mmol/l glucose plus 25 mmol/l KCl (d)
and 22.2 mmol/l glucose plus 25 mmol/l KCl, 0.5 mmol/l IBMX,
100 nmol/l PMA and 10 µmol/l forskolin (e). Scale bar, 200 µm
Table 1 Insulin secretion from single beta cells evaluated per donor by RHPA after stimulation with 22.2 mmol/l glucose, with corresponding
pancreas and beta cell characteristics
Donor
number
TPD
(μm2)
PFC
(%)
MPA
(μm2)
Age
(years)
BMI
(kg/m2)
Glycaemiaa
(mmol/l)
Cold ischaemia
timeb (h)
Warm ischaemia
timec (min)
Beta cell
viabilityd (%)
Beta cell
content (%)
1 286,913 67.5 4,251 39 21 NA 5.0 133 NA NA
2 209,644 76.7 2,734 57 20 9.7 8.5 60 95.30 58.6
3 395,678 86.7 4,566 22 28 6.1 12.4 115 90.90 66.1
4 328,735 75.3 4,364 56 28 13.5 6.0 87 94.80 71
5 257,143 72.9 3,530 57 23 13.2 11.3 80 96.10 49.1
6 408,738 79.2 5,138 40 36 5.4 11.0 68 97.30 67.7
7 91,897 40.6 2,262 55 28 13.6 6.4 85 97.60 66.6
8 95,819 47.5 2,017 54 26 8.8 10.5 87 96.80 57
9 408,567 75.6 5,405 42 25 11.1 8.9 36 98.50 40.8
10 387,370 69.2 5,595 43 26 NA 5.1 86 98.60 51.6
11 354,894 88.3 4,018 50 24 5.6 6.5 60 99.20 52.7
12 268,756 68.9 3,903 42 25 6.2 5.1 64 99.20 46.1
13 199,795 58.9 3,391 50 20 5.1 2.4 63 98.50 43.7
14 245,386 64.3 3,817 23 23 7.0 7.0 41 99.30 41.8
15 270,918 64.6 4,196 63 23 9.0 8.8 118 98.40 50.7
Correlation
with TPDe
−0.43 (0.11) 0.35 (0.21) −0.08 (0.78) 0.19 (0.51) −0.04 (0.88) −0.02 (0.95) 0.01 (0.96)
Correlation
with PFCe
−0.30 (0.27) 0.12 (0.66) −0.18 (0.56) 0.30 (0.28) −0.09 (0.74) −0.25 (0.39) 0.07 (0.82)
Correlation
with MPAe
−0.42 (0.12) 0.31 (0.26) 0.07 (0.82) 0.01 (0.96) −0.01 (0.98) 0.16 (0.57) −0.11 (0.71)
a Last glycaemia measured before pancreas removal
b Time between aortic clamp and start of islet isolation
c Time between aortic clamp and pancreas removal
d Beta cells that were Trypan Blue negative
e Correlation coefficient (and corresponding p value)
NA, not available
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tration most cells (80%) secreted low amounts of insulin or
did not secrete at all. The proportion of cells forming small
haemolytic plaques was independent of glucose concentra-
tion (9–12% of total beta cell population). In contrast, the
frequency of cells forming plaques with a higher diameter
gradually increased with glucose concentration, reaching a
maximum of 17% for beta cells forming plaques with a
diameter of 75 μm. When TPD was expressed as a function
of plaque diameter (Fig. 4b), we observed that TPD values
were very small for beta cells forming plaques with small
diameters, even if, as shown in Fig. 4a, these cells were the
most numerous. As shown in Fig. 4b, at both 2.2 and
22.2 mmol/l glucose, haemolytic plaques with 50 μm
diameter or below made a low contribution to total insulin
secreted. TPD values were considerably higher for beta
cells forming plaques with larger diameters (Fig. 4b), even
though these cells were less numerous (Fig. 4a). As a
consequence of this secretion pattern, we calculated that
20% of the total beta cell population was secreting 90% and
70% of the total amount of insulin released at low and high
glucose concentrations, respectively (Fig. 4c).
Differential secretory response to glucose between single
and aggregated beta cells As shown above (Fig. 2), insulin
secretion of single beta cells was not increased at
22.2 mmol/l glucose as compared with 12.2 mmol/l glucose.
This result was surprising, given that insulin release has
often been shown to increase dose-dependently with
glucose concentrations from 2.2 to 16.7 or 22.2 mmol/l.
We sought to elucidate whether the loss of some character-
istics expressed in islets, such as cell-to-cell contacts and
paracrine interactions, could be responsible for the singular
secretory pattern of single beta cells. To this end, we
studied in a first set of experiments haemolytic plaques
developed around: (1) single beta cells; (2) cell pairs
formed by two contacting beta cells (beta–beta pairs); and
(3) pairs formed by one beta cell contacting one non-beta
cell (beta–non-beta pairs) (Fig. 5). As already shown above,
TPD of single beta cells was low at 2.2 mmol/l glucose,
Fig. 4 Secretion pattern in relation to the size of haemolytic plaques.
a Percentage of secreting beta cells according to the diameter of
haemolytic plaques (μm). At 22.2 mmol/l glucose (white bars),
percentages of large haemolytic plaques were increased compared with
low glucose condition (black bars) where small haemolytic plaques
predominated. b TPD according to the diameter of haemolytic plaques
(μm). At 22.2 mmol/l glucose (white bars), values were higher than at
2.2 mmol/l (black bars), especially for larger haemolytic plaques; the
maximum TPD values were from beta cells with large-diameter
haemolytic plaques, as shown by values for 107–150 μm at
22.2 mmol/l glucose, even if the corresponding percentage (a) of these
cells was low. c TPD of the 20% of cells secreting greater levels of
insulin (grey bars) compared with global TPD (white bars) after 2.2 and
22.2 mmol/l glucose stimulation. The 20% of cells secreting greater
levels of insulin accounted for 90% and 70% of the total insulin secreted
after 2.2 and 22.2 mmol/l glucose stimulation, respectively; n=9
Fig. 5 Insulin secretion of single and paired cells. Photomicrographs of a
single beta cell (a), a beta cell paired with non-beta cell (b) and a beta
cell paired with another beta cell (c) surrounded by a haemolytic plaque.
Scale bar, 50 μm. d Corresponding TPD of cells as indicated, evaluated
after stimulation with 2.2 (black bars), 12.2 (hatched bars) and
22.2 mmol/l (white bars) glucose. For single beta cells and beta cells
paired with non-beta cells (beta–non-beta), TPD increased significantly
at 12.2 and 22.2 mmol/l compared with 2.2 mmol/l glucose stimulation,
and did not increase further at 22.2 mmol/l compared with 12.2 mmol/l.
For beta cell pairs (beta–beta), TPD gradually increased with glucose
concentration. n=5; *p<0.05 compared with 2.2 mmol/l glucose,
†p<0.05 compared with 2.2 and 12.2 mmol/l glucose
1848 Diabetologia (2008) 51:1843–1852
increased three- to fourfold at 12.2 mmol/l glucose, but did
not increase any more at 22.2 mmol/l glucose. TPD of
beta–non-beta pairs was not significantly different from that
of single beta cells at any glucose concentrations. By
contrast, TPD of beta–beta pairs was increased as compared
with single beta cells and beta–non-beta pairs at any
glucose concentration (p<0.05). In addition, TPD of beta–
beta pairs at 22.2 mmol/l glucose was enhanced up to 1.8-
fold compared with 12.2 mmol/l glucose (p<0.05).
Because of the well-known effect of hormones, such as
glucagon and somatostatin, on insulin secretion, we
identified in a different set of experiments the non-beta
partner in beta–non-beta aggregates by double fluorescence
immunostaining. When insulin and glucagon were stained
(Fig. 6a), we observed that aggregates comprising a beta
cell coupled to an alpha cell (beta–alpha pairs) secreted
significantly more insulin than beta cells alone (Fig. 6b).
This effect was attributable to an increase in both PFC and
MPA (not shown) and was observed at 12.2 and
22.2 mmol/l glucose (Fig. 6b). When insulin and somato-
statin were stained, we observed that TPD of beta–delta
pairs was unaffected at 12.2 and 22.2 mmol/l glucose, and
decreased (p<0.05) at 2.2 mmol/l glucose compared with
single beta cells or beta–non-beta–non-delta pairs (Fig. 6c).
In this set of experiments, beta–beta pairs were also
analysed (not shown); their secretion was increased
compared with single beta cells and similar to that of
beta–alpha pairs.
Different secretory response to glucose in mouse compared
with human islets Using static incubation tests, we studied
insulin secreted from intact human andmouse islets in response
to 1 h of stimulation with 2.2, 12.2 or 22.2 mmol/l glucose
(Fig. 7). In human islets, insulin secretion was increased
threefold at 12.2 compared with 2.2 mmol/l glucose and did
not increase any more at 22.2 mmol/l glucose. These results
were similar to those of experiments on single beta cells, beta–
non-beta and beta–alpha pairs. By contrast, in mouse islets,
Fig. 6 Insulin secretion of beta cells coupled to alpha and delta cells.
a A cell pair surrounded by a haemolytic plaque, shown by phase-
contrast and fluorescence illumination. Cells were stimulated for 1 h
with 22.2 mmol/l glucose and labelled by immunofluorescence for
insulin (green) and glucagon (red). Scale bars, 30 μm. b At the end of
the RHPA, cells were labelled for insulin and glucagon; we analysed
single beta cells, beta cells coupled to a non-beta–non-alpha cell
(Beta-X) and beta cells coupled to an alpha cell. TPD was evaluated
after 1 h stimulation with 2.2 (black bars), 12.2 (hatched bars) and
22.2 mmol/l glucose (white bars). Values are means±SEM of three
independent experiments. For each condition, about 350 single beta,
100 Beta-X and 300 beta–alpha cells were analysed. At 12.2 and
22.2 mmol/l glucose, TPD was higher (*p<0.05) for beta–alpha than
for single beta or Beta-X. c At the end of the RHPA, cells were
labelled for insulin and somatostatin, and single beta cells, beta cells
coupled to a non-beta–non-delta cell (Beta-X) and beta cells coupled
to a delta cell were analysed. TPD was evaluated after 1 h stimulation
as above (b). Values are means±SEM of three independent experi-
ments. For each condition, about 350 single beta, 300 Beta-X and 40
beta–delta cells were analysed. At 2.2 mmol/l glucose, TPD was lower
(*p<0.05) for beta–delta than for single beta or Beta-X
Fig. 7 Insulin secretion from intact islets. a, b Insulin secretion from
human (a) (n=7) and mouse (b) (n=3) islets was assessed by static
incubation after 1 h incubation at 2.2 (black bars), 12.2 mmol/
l (hatched bars) or 22.2 mmol/l (white bars). Results are expressed
relative to 2.2 mmol/l glucose. In human islets (a), insulin secretion at
22.2 mmol/l glucose was not significantly increased when compared
with 12.2 mmol/l glucose. In mouse islets (b), insulin secretion at
22.2 mmol/l glucose was higher (*p<0.05) than at 12.2 mmol/
l glucose and than the corresponding values of human islets. c, d
Sections of human and mouse pancreases respectively were labelled
for glucagon by immunofluorescence and islets were photomicro-
graphed. Alpha cells are scattered throughout whole human islet (c),
while in mouse islet (d) alpha cells occupy the periphery
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insulin release was increased fourfold at 12.2 compared with
2.2 mmol/l glucose, increasing even further by 1.5-fold at 22.2
compared with 12.2 mmol/l glucose. These results were
similar to those obtained with beta–beta pairs. Figure 7c,d
illustrates the cytoarchitecture of human and mouse islets,
respectively. In human islets, alpha cells were scattered
throughout the islet (Fig. 7c). By contrast, in mice, alpha
cells were mainly localised at the periphery of islets
(Fig. 7d). As result of this different organisation, there
were fewer homologous intercellular contacts between beta
cells in human than in mouse islets. It remains to be shown
whether the differences in cytoarchitecture between human
and rodent islets is the cause of their different sensitivity to
glucose. We are aware that other reasons may be involved,
such as dissimilarity in islet handling during and after
isolation.
Discussion
This study demonstrates that isolated human beta cells have
heterogeneous insulin secretory activity and that cell-to-cell
contact affects their insulin secretory activity.
Beta cell heterogeneity in terms of insulin secretion has
been described in rodents [10, 21, 26] and is described here
for the first time in humans. In rodents, beta cell heteroge-
neity was also observed in terms of metabolic, signalling [27,
28] and biosynthetic activities [12, 29]. Mechanisms explain-
ing heterogeneity of beta cells are totally unknown. It cannot
be completely ruled out that heterogeneity originates from
different levels of beta cell viability in the experimental
environment. However, more than 90% beta cells were
Trypan Blue-negative and only these were analysed for
insulin secretion. In addition, living cells were selected on the
basis of the presence of a refringent border corresponding to
an intact membrane. It is unlikely that heterogeneity could be
related to apoptosis. Indeed, we know from other experiments
performed under the same conditions (not shown) that less
than 5% beta cells were TUNEL-positive. After maximal
stimulation with a mixture of secretagogues comprising
glucose, KCl, IBMX, PMA and forskolin, the number of
non-secreting beta cells was largely decreased as compared
with glucose stimulation. This indicates that most non-
secreting cells under glucose stimulation were not damaged,
but may need to be stimulated with a secretagogue other than
glucose in order to secrete insulin. Whether heterogeneous
insulin secretion results from differential cellular insulin
contents is unknown and difficult to investigate. Using
immunofluorescence, we showed that virtually all beta cells
were strongly labelled for insulin and consequently were not
degranulated. This indicates that degranulation does not
account for the heterogeneity we observed in insulin
secretion. New technologies will be required to explore
whether more subtle differences in cellular insulin content
could have an effect on insulin secretion.
Even though heterogeneity of insulin secretion was
observed in all cell preparations, PFC, MPA and conse-
quently TPD varied considerably between cell preparations.
We assessed correlations between RHPA data and donor,
pancreas and islet cell characteristics. Characteristics that
varied highly between donors were age, BMI and glycae-
mia. None of these characteristics correlated with RHPA
data. Cold and warm ischaemia times are critical pancreas
variables that could affect insulin secretion. However, no
correlation was observed between ischaemia times and
RHPA data. At the cellular level, we analysed viability, beta
cell content and percentage of aggregated cells; again no
correlation was observed with RHPA data. It remains to be
investigated whether other cell characteristics, involving
glucose metabolism, cell signalling or insulin biosynthesis,
are related to insulin secretion outcome of beta cells.
Studying the repartition of secreting cells in relation to
plaque areas, we noticed that the majority of insulin was
secreted by very few beta cells. In fact, only 20% of the
total beta cell population secreted more than 90% and 70%
of the total amount of insulin released at low and high
glucose concentration, respectively. There is no evidence in
our data that this pattern of secretion exists in whole islets.
In rats, heterogeneous secretion of islet beta cells has been
demonstrated in vivo by systemic perfusion of glucose and
glibenclamide [30]. Of course, this kind of experiment is
impossible in humans. Based on several reports on the
‘pacemaker’ activity of islet cells [31], we speculate that the
cells secreting at high levels could act as ‘leader’ cells that
trigger insulin secretion from all beta cells within the same
islet. This could occur by cell synchronisation via calcium
influx through gap junctions [32, 33], via metabolic [29] or
by other extracellular signals [34, 35].
As expected from previous rodent studies [26, 30],
homologous contacts between human beta cells potentiated
insulin secretion. In addition, and for the first time, we
showed that a single intercellular contact between an alpha
cell and a beta cell was able to increase insulin secretion.
This effect could be explained by a paracrine action of
glucagon, meaning that the quantity of glucagon secreted
by a single alpha cell, even at high glucose concentration, is
sufficient to affect secretion of beta cells. Similar paracrine
mechanisms could account for the observed effect of delta
cells on insulin secretion. Our results are also consistent
with Pipeleers et al. [36], who demonstrated potentiation of
first and second insulin secretion phases in coupled rat beta
cells and reported that a fraction of beta cells enriched with
alpha cells had a secretory response comparable to coupled
beta cells [36]. Beside this paracrine hypothesis, it is
conceivable that adhesion and junctional molecules also
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play a role in the effect of homologous and heterologous
intercellular contacts on insulin secretion. Previous work
with rat beta cells has shown that intercellular coupling
through gap junctions is involved in glucose-regulated
insulin secretion [37]. Whether gap junctions or other types
of intercellular contact are involved in insulin secretion of
human beta cells remains to be investigated.
Intriguingly, insulin secretion in single beta cells was
similar at 12.2 and 22.2 mmol/l, a pattern which, just as
interestingly, was not found in beta cell pairs. Indeed, when
homologous contacts between beta cells were established (as
in beta cell pairs), insulin secretion was higher at 22.2 than at
12.2 mmol/l glucose. Therefore these results indicate that
homologous contacts between beta cells somehow improve
regulated insulin secretion, facilitating insulin secretion when
required by extreme metabolic needs. We propose that in
human islets, homologous beta cell contacts are reduced by the
high number of non-beta cells that are intermingled with beta
cells. Consequently in human islets no significant difference
could be observed between 22.2 and 12.2 mmol/l glucose. We
propose that total insulin secretion from human islets arises
from beta cells that are differently regulated according to their
neighbouring cells. At moderate glucose concentrations (up to
12.2 mmol/l), insulin secretion from beta cells is potentiated
by beta–beta and beta–alpha contacts and not affected or
possibly decreased by interactions with other islet cell
types. At higher glucose concentrations (22.2 mmol/l), only
beta–beta contacts may be able to further potentiate insulin
secretion. In rodent islets, homologous contacts between
beta cells are predominant and consequently a significant
difference is observed in insulin secretion between 22.2 and
12.2 mmol/l glucose.
Differences between species in islet architecture have
been described extensively elsewhere [20]. The implica-
tions of these findings in islet function have been
mentioned in terms of human beta cell de-synchronisation
within islets and high sensitivity of human islets to low
glucose concentrations [5]. From those findings and our
paired cell experiments, it seems that mostly paired cells in
the core of mouse islets have a high sensitivity to glucose
but poor control in case of rapid variations in the low-
glucose state [5], whereas human islets have a more
complex system of regulation with both cell-to-cell inhibi-
tion/activation of insulin secretion, higher glucagon content
and better control in the low-glucose state.
Taken together, our results demonstrate that individual
human beta cells are highly heterogeneous with regard to
their secretory activity and that both homologous and
heterologous intercellular contacts affect regulation of their
insulin secretion. We therefore propose that the particular
cytoarchitecture of human islets with abundant heterologous
cell-to-cell interactions may have a functional relevance in
the optimal regulation of insulin secretion.
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